Jan 14 (Reuters) - IntelliPharmaCeutics International Inc I.TO :
* Announces successful bioequivalence results for abuse deterrent Rexista(TM)
oxycodone xr
* Intends to file a new drug application for Rexista(TM) oxycodone xr with the
FDA within the next 6 months
* Source text for Eikon ID:nGNXMJDFXa
* Further company coverage I.TO